The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
trans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1
Abstract
The catalytic domain of the flavin-dependent human histone demethylase lysine-specific demethylase 1 (LSD1) belongs to the family of amine oxidases including polyamine oxidase and monoamine oxidase (MAO). We previously assessed monoamine oxidase inhibitors (MAOIs) for their ability to inhibit the reaction catalyzed by LSD1 [Lee, M. G., et al. (2006) Chem. Biol. 13, 563-567], demonstrating that trans-2-phenylcyclopropylamine (2-PCPA, tranylcypromine, Parnate) was the most potent with respect to LSD1. Here we show that 2-PCPA is a time-dependent, mechanism-based irreversible inhibitor of LSD1 with a KI of 242 microM and a kinact of 0.0106 s-1. 2-PCPA shows limited selectivity for human MAOs versus LSD1, with kinact/KI values only 16-fold and 2.4-fold higher for MAO B and MAO A, respectively. Profiles of LSD1 activity and inactivation by 2-PCPA as a function of pH are consistent with a mechanism of inactivation dependent upon enzyme catalysis. Mass spectrometry supports a role for FAD as the site of covalent modification by 2-PCPA. These results will provide a foundation for the design of cyclopropylamine-based inhibitors that are selective for LSD1 to probe its role in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Copeland, R. A. (2013) · Wiley eBooks · doi:10.1002/9781118540398 · Cited by 678
Histone demethylation catalysed by LSD1 is a flavin‐dependent oxidative process
Forneris, F., Binda, C., Vanoni, M. A., Mattevi, A., & Battaglioli, E. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.015 · Cited by 280
Human Histone Demethylase LSD1 Reads the Histone Code
Forneris, F., Binda, C., Vanoni, M. A., Battaglioli, E., & Mattevi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509549200 · Cited by 251
Structure-Function Relationships in Flavoenzyme-dependent Amine Oxidations
Binda, C., Mattevi, A., & Edmondson, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200005200 · Cited by 170
Silverman, R. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43725-2 · Cited by 92
Suicide inactivation of monoamine oxidase by trans-phenylcyclopropylamine.
Paech, C., Salach, J. I., & Singer, T. P. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85793-9 · Cited by 72
Aminopeptidase from Sphingomonas capsulata
Byun, T. S., Tang, M., Sloma, A., Brown, K. M., Marumoto, C., Fujii, M., & Blinkovsky, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010608200 · Cited by 15
Cited by
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G., et al. (2009) · Nature Genetics · doi:10.1038/ng.268 · Cited by 815
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Mosammaparast, N., & Shi, Y. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.070907.103946 · Cited by 585
Hayami, S., Kelly, J. D., Cho, H., Yoshimatsu, M., Unoki, M., Tsunoda, T., Field, H. I., Neal, D. E., Yamaue, H., Ponder, B. A. J., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25349 · Cited by 489
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Metadata
- Authors
- Schmidt, D. M. Z., & McCafferty, D. G.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-03-17
- Volume
- 46
- Issue
- 14
- Pages
- 4408-4416
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2013810007
- Cited by
- 307
- References
- 8
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.